Whole body hyperthermia: A phase-1 trial of a potential adjuvant to chemotherapy

Abstract Fourteen patients with a variety of neoplasms not responsive to standard forms of therapy underwent whole body hyperthermia for a maximum 4 h at 41.8 °C. This was a phase-l cancer trial de...